rhodamine 123 has been researched along with saquinavir in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dintaman, JM; Kim, AE; Silverman, JA; Waddell, DS | 1 |
| Back, DJ; Eagling, VA; Profit, L | 1 |
| Cauda, R; Leone, G; Lucia, MB; Rutella, S; Vella, S | 1 |
| Béïque, L; Cameron, DW; Chauhan, B; Foster, BC; Garber, GE; la Porte, CJ; Li, Y; van Heeswijk, RP | 1 |
| Al-Jayyoussi, G; Eddershaw, P; Edwards, CD; Francombe, D; Gumbleton, M; Morris, C; Price, DF; Smith, MW; Taylor, G | 1 |
1 trial(s) available for rhodamine 123 and saquinavir
| Article | Year |
|---|---|
The effect of ABCB1 polymorphism on the pharmacokinetics of saquinavir alone and in combination with ritonavir.
Topics: Administration, Oral; Adult; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Combinations; Exons; Genotype; Haplotypes; HIV Protease Inhibitors; Humans; Leukocytes, Mononuclear; Longitudinal Studies; Phenotype; Polymorphism, Single Nucleotide; Reference Values; Rhodamine 123; Ritonavir; RNA, Messenger; Saquinavir | 2007 |
4 other study(ies) available for rhodamine 123 and saquinavir
| Article | Year |
|---|---|
Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein.
Topics: 3T3 Cells; Animals; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Cyclosporine; HIV Protease Inhibitors; Mice; Rhodamine 123; Rhodamines; Saquinavir | 1998 |
Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Flow Cytometry; Fluorescent Dyes; HIV Protease Inhibitors; Humans; Indinavir; Lymphocytes; Nelfinavir; Rhodamine 123; Ritonavir; Saquinavir; Temperature; Verapamil | 1999 |
HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART.
Topics: Adult; Antigens, CD34; Antiretroviral Therapy, Highly Active; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Fluorescent Dyes; Hematopoietic Stem Cells; HIV Infections; HIV Protease Inhibitors; Humans; In Vitro Techniques; Indinavir; Lymphocytes; Male; Nelfinavir; Rhodamine 123; Ritonavir; RNA, Viral; Saquinavir | 2001 |
Selectivity in the impact of P-glycoprotein upon pulmonary absorption of airway-dosed substrates: a study in ex vivo lung models using chemical inhibition and genetic knockout.
Topics: Animals; Anti-Arrhythmia Agents; Antidiarrheals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; Biological Transport; Digoxin; Dogs; Gene Knockout Techniques; HIV Protease Inhibitors; Humans; Loperamide; Lung; Madin Darby Canine Kidney Cells; Male; Mice; Mice, Knockout; Permeability; Rats; Rats, Sprague-Dawley; Rhodamine 123; Saquinavir | 2013 |